“The underlying mechanisms is dosage‐dependent: Salmeterol at 10−10 M shows anti‐inflammatory effects through &bgr;‐arrestin2 pathway, and 10−7 M Salmeterol inhibits inflammation via both classical G‐protein coupled receptor (GPCR)/cAMP pathway and &bgr;‐arrestin2 pathway.”